Breaking News

Exyte Builds mRNA Competence Center for Wacker in Halle

Project is part of the German government's program to prepare for future pandemics.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Exyte GmbH, offering services for the design, engineering and delivery of facilities for high-tech industries, is building a mRNA competence center at the Halle Biotech site of Wacker Chemie AG. The project, the company said, is making a considerable contribution towards strengthening the biopharma and life sciences segment at Exyte. Construction has started at the Wacker Biotech site in the Weinberg Campus technology park. The Wacker Group concentrates its biopharmaceuticals activities withi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters